Cervical Cancer Screening (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (06/14/2018)

Added text to state that in a review of data from a large integrated health system, the added benefit of cotesting versus human papillomavirus (HPV) testing alone would improve detection of cervical intraepithelial neoplasia (CIN) 3 or early-stage cervical cancer in very few women; only 5.1% of locally advanced invasive cancers and 3.6% of CIN 3 were cytology positive and HPV negative, representing a very small fraction of all screened women (cited Schiffman et al. as reference 68).

This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Evidence of Harm

Next section >
About This PDQ Summary